go back

Nevada rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $1,122,018 · 10th–90th $0–$1,412,5380%50%10th90th$1,122,018Professionalmedian $562,341 · 10th–90th $562,341–$645,6540%50%90th$562,341$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $1,122,018.45 / $1,412,537.54
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $645,654.23
Anthem BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$0.03 / $0.03 / $0.03
Anthem BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $562,341.33
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $676,082.98
Hometown Health
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$575,439.94 / $575,439.94 / $575,439.94
Select Health
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $588,843.66
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$512,861.38 / $645,654.23 / $851,138.04